NasdaqCM - Nasdaq Real Time Price USD
Iterum Therapeutics plc (ITRM)
1.2901
-0.0999
(-7.19%)
As of 1:28:10 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-26,770
-26,770
-39,330
-18,473
-15,842
Investing Cash Flow
18,208
18,208
23,336
13,957
-54,595
Financing Cash Flow
26,691
26,691
1,034
-1,818
83,127
End Cash Position
24,159
24,159
6,105
21,126
27,510
Income Tax Paid Supplemental Data
220
220
401
821
435
Interest Paid Supplemental Data
--
--
--
22
416
Capital Expenditure
-2
-2
-13
-62
-61
Issuance of Capital Stock
26,691
26,691
1,034
433
89,643
Repayment of Debt
--
--
--
-2,251
-6,516
Free Cash Flow
-26,772
-26,772
-39,343
-18,535
-15,903
12/31/2021 - 5/25/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLS SELLAS Life Sciences Group, Inc.
1.3350
+1.91%
SPRO Spero Therapeutics, Inc.
0.7330
+0.81%
CMND Clearmind Medicine Inc.
0.9900
-0.49%
PSTV Plus Therapeutics, Inc.
0.8802
-10.50%
BCTX BriaCell Therapeutics Corp.
6.84
+25.96%
MIST Milestone Pharmaceuticals Inc.
1.2050
+3.88%
LXRX Lexicon Pharmaceuticals, Inc.
0.7323
+9.01%
APVO Aptevo Therapeutics Inc.
0.6780
-8.39%
SLXN Silexion Therapeutics Corp
0.9692
-5.90%
PHIO Phio Pharmaceuticals Corp.
2.1850
+7.11%